This phenomenon may be related to a compensatory response of adipose tissue to adiponectin resistance state due to the down-regulation and/or phosphorylation of adiponectin receptor, which have been documented in cardiovascular disease [30]. Here, ADIPOQ is linked to cardiovascular disorder.